Stock market today: insider buys and sells, Tuesday, March 3, 2026
Corporate insiders filed 14 open-market purchases worth $30.9M and 282 sales worth $321M. The S&P 500 (SPY) fell 0.9% on the day.
Biggest insider buys
- Buy
WRB 10% Owner Sumitomo Insurance Co Ltd Mitsui bought $7.4M of WRB at $73.20.
- Buy
WRB 10% Owner Sumitomo Insurance Co Ltd Mitsui bought $5.3M of WRB at $72.52.
- Buy
KKR CEO Joseph Y Bae bought $4.4M of KKR at $88.56.
- Buy
KKR CEO Scott C Nuttall bought $4.4M of KKR at $87.81.
- Buy
WRB 10% Owner Sumitomo Insurance Co Ltd Mitsui bought $3.3M of WRB at $72.29.
- Buy
WRB 10% Owner Sumitomo Insurance Co Ltd Mitsui bought $2.8M of WRB at $71.60.
- Buy
KKR Director Mary N Dillon bought $2.0M of KKR at $90.96 — first open-market purchase in our records; raises the stake by 81%.
- Buy
CSGP President Frederick G. Saint bought $907K of CSGP at $45.33 — first open-market purchase in our records.
- Buy
ZBRA Director Satish Dhanasekaran bought $113K of ZBRA at $225.25.
- Buy
SJM Director Tarang Amin bought $100K of SJM at $113.41 — first open-market purchase in our records; raises the stake by 23%.
Biggest insider sales
| Stock | Insider | Value | Plan |
|---|---|---|---|
| NFLXNetflix Inc | Reed HastingsDirector | $22.1M | 10b5-1 |
| NFLXNetflix Inc | Reed HastingsDirector | $12.5M | 10b5-1 |
| SYFSynchrony Financial | Brian D DoublesSee Remarks | $10.3M | 10b5-1 |
| CFCF Industries Holdings, Inc. | W Anthony WillCEO, President | $9.9M | — |
| LRCXLam Research Corp | Douglas R BettingerCFO | $9.3M | — |
| VRTXVertex Pharmaceuticals Inc / Ma | Reshma KewalramaniCEO, President | $7.7M | 10b5-1 |
| METAMeta Platforms, Inc. | Susan J LiCFO | $7.6M | 10b5-1 |
| METAMeta Platforms, Inc. | Susan J LiCFO | $7.3M | 10b5-1 |
| KOCoca Cola Co | John MurphyCFO, President | $5.8M | — |
| CVXChevron Corp | R. Hewitt PateGeneral Counsel | $5.5M | 10b5-1 |
Biggest moves among these stocks
Share-price change on the day, for stocks with insider filings.
Filing dates are when the SEC received each Form 4; trades can be up to two business days earlier. Facts from public filings, not investment advice.